Neuroendocrine Modulation of Cognitive Performance in the Patients with Fibromyalgia

Background: Fibromyalgia (FM) is a chronic widespread pain disorder associated with fatigue, tender points, sleep disturbances, and mood disorders. Symptoms associated with FM also include decreased cognitive function in which the neural basis is poorly understood. Neuroendocrine hormones may be correlated with cognitive performance under some ill conditions. However, we are unaware of current evidence on neuroendocrine hormones as factors influencing cognitive function in adults with FM. Objectives: The aim of the study was to assess whether neuroendocrine hormones could affect cognition in the patients with FM. Study Design: This study used a case-control trial design. Setting: Study patients were recruited from the neurological outpatient clinics in the Second Affiliated Hospital and Affiliated Chaohu Hospital of Anhui Medical University and met the American College of Rheumatology criteria for FM. Methods: Forty-six patients with FM were compared with twenty-nine healthy controls (HCs). Several measures of cognitive performance and serum levels of neuroendocrine hormones were used to make these comparisons, and the patients were also asked to complete questionnaires on depression and sleep quality. Partial correlation analysis was performed to control the confounders and linear regression analysis was used to examine the effects of neuroendocrine hormones on cognitive measures. Results: The FM patients had worse performance in attention, short-term memory, orientation, object working memory and spatial reference memory, higher depression scores, and worse sleep quality than HCs. The raised level of cortisol and gonadotropin-releasing hormone (GnRH) can protect general cognition, whereas the raised level of cortisol and thyroid-stimulating hormone (TSH) will damage spatial memory. Limitations: We did not study the sex hormones comprehensively. Conclusions: The FM patients showed significant cognitive impairment in several domains. The altered levels of cortisol, thyrotrophin-releasing hormone (TRH), and GnRH may mediate cognitive changes in FM.

[1]  T. Palomo,et al.  Hypothalamic-pituitary axis response to a 0.25-MG dexamethasone test in women with fibromyalgia , 2020, Stress.

[2]  Hamid Fekri Azgomi,et al.  A System Theoretic Investigation of Cortisol Dysregulation in Fibromyalgia Patients with Chronic Fatigue , 2019, 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[3]  H. Asada,et al.  Sleep Shortage Is Associated With Postherpetic Neuralgia Development Through Hyperesthesia and Acute Pain Intensity: A Community‐Based Prospective Cohort Study , 2019, Pain practice : the official journal of World Institute of Pain.

[4]  Yong-Mei Zhang,et al.  Involvement of dopamine system in the regulation of the brain corticotropin-releasing hormone in paraventricular nucleus in a rat model of chronic visceral pain , 2018, Neurological research.

[5]  Gui-Hai Chen,et al.  Cognitive Performance and the Alteration of Neuroendocrine Hormones in Chronic Tension‐Type Headache , 2018, Pain practice : the official journal of World Institute of Pain.

[6]  D. Y. Lee,et al.  Sex-specific association of sex hormones and gonadotropins, with brain amyloid and hippocampal neurodegeneration , 2017, Neurobiology of Aging.

[7]  N. Hattori,et al.  High prevalence of anti‐TSH receptor antibody in fibromyalgia syndrome , 2017, International journal of rheumatic diseases.

[8]  Adriana B Ferreira,et al.  Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin , 2017, Molecular Psychiatry.

[9]  N. Inestrosa,et al.  Induction of hypothyroidism during early postnatal stages triggers a decrease in cognitive performance by decreasing hippocampal synaptic plasticity. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[10]  N. Mickuvienė,et al.  Cognitive Functioning in Coronary Artery Disease Patients: Associations with Thyroid Hormones, N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein , 2017, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[11]  C. Soriano-Mas,et al.  Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status , 2017, Psychoneuroendocrinology.

[12]  A. Kakita,et al.  Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism , 2016, Internal medicine.

[13]  C. Fernández‐de‐las‐Peñas,et al.  Cognitive performance in women with fibromyalgia: A case-control study. , 2016, Australian occupational therapy journal.

[14]  F. Wang,et al.  Patients with chronic insomnia have selective impairments in memory that are modulated by cortisol. , 2016, Psychophysiology.

[15]  M. Semiz,et al.  Serum cortisol and dehydroepiandrosterone-sulfate levels after balneotherapy and physical therapy in patients with fibromyalgia , 2016, Saudi medical journal.

[16]  I. Russell,et al.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells , 2016, The Journal of Pharmacology and Experimental Therapeutics.

[17]  Wensheng Guo,et al.  Modeling diurnal hormone profiles by hierarchical state space models , 2015, Statistics in medicine.

[18]  T. Lallukka,et al.  Sleep and pain sensitivity in adults , 2015, Pain.

[19]  W. Kong,et al.  Reliability and Validity of the Beijing Version of the Montreal Cognitive Assessment in the Evaluation of Cognitive Function of Adult Patients with OSAHS , 2015, PloS one.

[20]  S. Noten,et al.  Cognitive Performance Is Related to Central Sensitization and Health-related Quality of Life in Patients with Chronic Whiplash-Associated Disorders and Fibromyalgia. , 2015, Pain physician.

[21]  K. Sluka,et al.  Do Cognitive and Physical Fatigue Tasks Enhance Pain, Cognitive Fatigue, and Physical Fatigue in People With Fibromyalgia? , 2015, Arthritis care & research.

[22]  M. Gingnell,et al.  Menstrual cycle influence on cognitive function and emotion processing—from a reproductive perspective , 2014, Front. Neurosci..

[23]  C. Boettiger,et al.  Ovarian Cycle Effects on Immediate Reward Selection Bias in Humans: A Role for Estradiol , 2014, The Journal of Neuroscience.

[24]  C. Scheidt,et al.  Self-reported symptoms of pain and depression in primary fibromyalgia syndrome and rheumatoid arthritis , 2014, Nordic journal of psychiatry.

[25]  F. Wolfe,et al.  Prevalence of Fibromyalgia: A Population‐Based Study in Olmsted County, Minnesota, Utilizing the Rochester Epidemiology Project , 2013, Arthritis care & research.

[26]  D. Chialvo,et al.  Age-of-onset of menopause is associated with enhanced painful and non-painful sensitivity in fibromyalgia , 2013, Clinical Rheumatology.

[27]  S. Tufik,et al.  Sleep Disorders and Fibromyalgia , 2011, Current pain and headache reports.

[28]  J. Lupiáñez,et al.  Attentional deficits in fibromyalgia and its relationships with pain, emotional distress and sleep dysfunction complaints , 2011, Psychology & health.

[29]  D. Hellhammer,et al.  Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. , 2010, The journal of pain : official journal of the American Pain Society.

[30]  H. Brown-Borg,et al.  Assessment of spatial memory in mice. , 2010, Life sciences.

[31]  Paul Jarle Mork,et al.  Fibromyalgia Syndrome is Associated with Hypocortisolism , 2010, International journal of behavioral medicine.

[32]  F. Wolfe,et al.  The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity , 2010, Arthritis care & research.

[33]  Patrick Luyten,et al.  Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? , 2009, Medical hypotheses.

[34]  Saifudin Rashiq,et al.  Disruption of cognitive function in Fibromyalgia Syndrome , 2008, PAIN.

[35]  J. Kratzsch,et al.  Thyroid gland development and defects. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[36]  R. Craft.  Modulation of pain by estrogens , 2007, PAIN.

[37]  M. Behbehani,et al.  Sensitization of the Trigeminal Sensory System During Different Stages of the Rat Estrous Cycle: Implications for Menstrual Migraine , 2007, Headache.

[38]  Jennifer M. Glass,et al.  Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions , 2006, Current rheumatology reports.

[39]  H. D. de Vet,et al.  Hormonal and Reproductive Factors are Associated With Chronic Low Back Pain and Chronic Upper Extremity Pain in Women–The MORGEN Study , 2006, Spine.

[40]  C. Nemeroff,et al.  The neurobiology of depression: inroads to treatment and new drug discovery. , 2005, The Journal of clinical psychiatry.

[41]  Leslie A. McClure,et al.  Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome , 2004, Brain, Behavior, and Immunity.

[42]  J. Balthazart,et al.  Aromatization of androgens into estrogens reduces response latency to a noxious thermal stimulus in male quail , 2004, Hormones and Behavior.

[43]  P. Salmon,et al.  Biological and psychological factors associated with memory function in fibromyalgia syndrome. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[44]  S. Wood,et al.  The Nine Box Maze Test: A measure of spatial memory development in children , 2003, Brain and Cognition.

[45]  M. Harth,et al.  Classification, epidemiology, and natural history of fibromyalgia , 2001, Current pain and headache reports.

[46]  E. D. Haan,et al.  Varieties of human spatial memory: a meta-analysis on the effects of hippocampal lesions , 2001, Brain Research Reviews.

[47]  R. Sapolsky,et al.  How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. , 2000, Endocrine reviews.

[48]  M. Demitrack,et al.  Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. , 1996, Rheumatic diseases clinics of North America.

[49]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[50]  E. Orozco-Acosta,et al.  Serum cortisol levels and neuropsychological impairments in patients diagnosed with Fibromyalgia. , 2018, Actas espanolas de psiquiatria.

[51]  C. Pantelis,et al.  University of Birmingham Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis , 2017 .

[52]  F. Leavitt,et al.  Distraction as a key determinant of impaired memory in patients with fibromyalgia. , 2006, The Journal of rheumatology.

[53]  D. Wendling,et al.  Fibromyalgia Developed after Administration of Gonadotrophin- Releasing Hormone Analogue , 2001, Clinical Rheumatology.

[54]  L. H. Graf,et al.  Mutations in the c-erbA beta 1 gene: do they underlie euthyroid fibromyalgia? , 1997, Medical hypotheses.

[55]  G. Chrousos,et al.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. , 1997, Neuroimmunomodulation.